ROBO1 and non-small cell lung carcinoma: miR-32 and miR-548a were poorly expressed in DDP-resistant NSCLC, re-expression of miR-32 and miRNA-548a promotes the sensitivity of NSCLC cells to cisplatin by targeting ROBO1/β-catenin axis [226].